Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-K stay in one workspace.
ELTP
$0.25
+1.02%
ELTP
· Elite Pharmaceuticals Inc
$0.25
+0.00 (+1.02%)
At close · Oct 22
Return incl. dividend (before tax)
Going-concern doubt
— cleared Aug 13, 2026
The latest filing no longer states the doubt (first flagged Jun 29, 2026).
View the 10-Q filed Aug 13, 2026Market Cap
$269.28M
Shares
1.08B
Volume · Oct 22
258.92K
Avg daily vol (3M)
772.21K
All webcasts
Earnings call · FY2026 Q4
Elite Pharmaceuticals Inc (ELTP) Q4 2026 Earnings Call
Revenue · derived Q4
$40.75M
+27.4% YoY
Gross margin · derived Q4
51.0%
-3.1 pp YoY
Net income · derived Q4
$18.46M
+8.6% YoY
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Jun 29, 2026 · complete as-filed document
SEC periodic report
10-K report
Filed Jun 29, 2026 · complete as-filed document